Log In
BCIQ
Print this Print this
 

OTX-101

  Manage Alerts
Collapse Summary General Information
Company Ocular Technolgies S.a.r.l.
DescriptionUndislcosed
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II/III
Standard IndicationDry eye
Indication DetailsTreat keratoconjunctivitis sicca (KCS)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today